Real-World Data Study Shows Biosimilar Rituximab for Rheumatoid Arthritis Safe and Effective

April 11th, 2023|Categories: Featured, Industry News|Tags: , , , , |

A new real-world data (RWD) study published in Rheumatology International found that patients with rheumatoid arthritis who switched from Roche’s biosimilar rituximab to Rixathon’s version of the biosimilar did not suffer any deterioration. Patients who had not taken any version of rituximab also saw similar benefits.

Go to Top